UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010549 |
|---|---|
| Receipt number | R000012334 |
| Scientific Title | Phase II study of Temozolomide monotheraphy in patients with first line treatment-refractory neuroendocrine carcinoma |
| Date of disclosure of the study information | 2013/04/20 |
| Last modified on | 2017/10/26 23:11:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/04/19 20:42:13 | ||
| 2 | Update | 2014/10/24 17:26:02 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 Key exclusion criteria |
|
| 3 | Update | 2014/10/24 17:27:15 | TEL Last name of contact person Last name of contact person TEL |
|
| 4 | Update | 2014/12/22 19:45:17 | Interventions/Control_1 |
|
| 5 | Update | 2016/09/17 10:28:20 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2017/04/22 15:01:36 | Recruitment status |
|
| 7 | Update | 2017/10/26 23:11:13 | Recruitment status |
